NCT04805385View on ClinicalTrials.gov

Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome

NACompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Tourette's Syndrome

Interventions

DIETARY_SUPPLEMENT

PS128

Each PS128 capsule contained \>1 × 10\^10 colony forming units (CFU) with microcrystalline cellulose and weights 425 ± 25 mg The placebo capsules only contained 425 ± 25 mg microcrystalline cellulose

Trial Locations (1)

404332

China Medical University Hospital, Taichung

All Listed Sponsors

collaborator

Bened Biomedical Co., Ltd.

INDUSTRY

lead

China Medical University Hospital

OTHER

NCT04805385 - Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome | Biotech Hunter | Biotech Hunter